New Delhi, March 20 -- Everhope Oncology, a joint venture between a hospital network, venture capital firm, and a healthcare-focused venture studio, has secured seed funding, while health and wellness brand My Pahadi Dukan has raised pre-seed funding.
Everhope Oncology
Narayana Health, an established hospital network, early-stage venture capital firm W Health Ventures, and healthcare venture studio 2070 Health launched a joint venture called Everhope Oncology, which has raised $10 million (Rs 86.3 crore) in seed funding.
With the number of cancer cases rising in India, the company aims to address the gap in healthcare infrastructure by establishing chemotherapy facilities and specialized surgical centers.
The funds will be used to set up cancer care facilities in Delhi and Mumbai, with plans to expand to 10 cities over the next three years.
These centers will provide comprehensive cancer care, including diagnosis, chemotherapy, radiation, surgery, and palliative care.
My Pahadi Dukan
My Pahadi Dukan, a direct-to-consumer (D2C) brand, has raised an undisclosed amount of pre-seed funding from Inflection Point Ventures (IPV).
The funds will be used to enhance the brand's marketing, strengthen working capital, and improve its operations and IT infrastructure.
The brand offers a range of Himalayan health and wellness products, including coffee, ghee and honey, and claims to collaborate with over 20,000 farmers, self-help groups (SHGs), cooperatives, and households. It sources products from nine Himalayan states and Bhutan, shipping to over 29 countries, and has fulfilled over 16,000 orders.
It was founded in 2021 by Himanshu Dua, Shubham Tandon, Rohan Sehgal, and Mohd. Anas Zubair in Uttarakhand.
Published by HT Digital Content Services with permission from VC Circle.